Stock research
ARWR — ARROWHEAD PHARMACEUTICALS IN
ARWR is reported by 6 tracked managers with $163.9M in visible reported value. This page connects ownership breadth, filing activity, and price context.
Stock research evidence
The latest visible filing snapshot is 2026 Q2. Values come from reported manager holdings; prices and 52-week context come from the latest available market quote.
- Tracked holders
- 6
- Reported value
- $163.9M
- Ownership breadth
- Not available
- Current price
- $83
Top reported managers
These managers have the largest visible reported positions in ARWR. Portfolio weight is measured within each manager's latest visible filing.
- John Overdeck / David Siegel0% of reported portfolio · $47.3M · Add · Filed Aug 14, 2026
- Jim Simons0.1% of reported portfolio · $38.2M · Reduce · Filed Aug 13, 2026
- David Shaw0% of reported portfolio · $35.2M · Reduce · Filed Aug 14, 2026
- Israel Englander0% of reported portfolio · $26.8M · Filed Aug 14, 2026
- Cliff Asness0% of reported portfolio · $15.8M · Filed Aug 14, 2026
Continue the research
Review the manager roster, compare this company with the most widely held stocks, or browse transparent screens built from the same filing-backed data.